Medical Information Only. Always consult your healthcare provider before enrolling in any clinical trial.
NCT00000402 · ClinicalTrials.gov registry record · Phase 2
Calcium and Bone Mass in Young Females
A Phase 2 study of Osteoporosis, sponsored by Ohio State University.
- Completed
- Registry status
- Phase 2
- Development phase
- 354
- Enrollment target
- 1
- Study location
NCT00000402: Completed Phase 2 study of Osteoporosis, sponsored by Ohio State University.
NCT00000402 is a Phase 2 study of Osteoporosis that has completed, run by Ohio State University. The registered enrollment target is 354 participants, below the 1,542-participant average among 84 other Osteoporosis trials with a reported enrollment target (77% lower). The trial reports 1 study location across 1 state. According to ClinicalTrials.gov, the official US trial registry.
The verdict
NCT00000402, a Phase 2 study of Osteoporosis, has completed, sponsored by Ohio State University.
- COMPLETED
- Registry status
- Phase 2
- Development phase
- 354 participants
- Enrollment target
- 1
- Study location
Study Summary
We originally suggested that calcium in the diet is important in determining the amount of bone (bone mass) that builds up in young adults. We are testing the effect of calcium on bone mass in 354 Caucasian (white) girls. At the start of this 7-year study, the average age of the girls was 11 years, and they had not yet reached puberty. The study will also provide information about the effect of calcium on body composition (body fat) and blood pressure in young women. We have been giving calcium to one group of participants in this study and giving a placebo (an inactive pill, or "sugar pill") to the other group. The results of this research will be important in preventing osteoporosis, because building more bone as a young person should reduce a woman's chances of developing osteoporosis later in life.
Conditions Studied
Interventions
- DRUG Calcium
Study Locations (1)
Ohio
- OSU Bone and Mineral Metabolism Laboratory - Columbus
Trial Details
| Field | Value |
|---|---|
| Enrollment Target | 354 participants |
| Start Date | 1991-08 |
| Est. Completion | 2001-12 |
| Phase | Phase 2 |
What the finished NCT00000402 record still lists
NCT00000402 is an interventional study that assigns participants to a tested intervention. The registered 354 participants enrollment target is mid-sized for trials with a published cap, below the 1,542-participant average among 84 other Osteoporosis trials with a reported enrollment target (77% lower).
The record links to 1 condition, with Osteoporosis appearing as the primary indexed condition, and to 1 intervention - of which Calcium is the first listed.
NCT00000402 reports a single indexed study location in Ohio.
Frequently Asked Questions
What is clinical trial NCT00000402 about?
NCT00000402 is a clinical study titled "Calcium and Bone Mass in Young Females". We originally suggested that calcium in the diet is important in determining the amount of bone (bone mass) that builds up in young adults. We are testing the effect of calcium on bone mass in 354 Caucasian (white) girls. At the start of this 7-year study, the average age of the girls was 11 years, ...
What is the current status of trial NCT00000402?
This trial is currently completed. It is a Phase 2 study. The enrollment target is 354 participants. The study started on 1991-08. Estimated completion is 2001-12.
What conditions does trial NCT00000402 study?
This clinical trial studies the following conditions: Osteoporosis.
What interventions are being tested in trial NCT00000402?
The interventions under investigation include: Calcium (DRUG).
Who is sponsoring clinical trial NCT00000402?
This trial is sponsored by Ohio State University, which has 552 total clinical trials registered on ClinicalTrials.gov.
Where is trial NCT00000402 being conducted?
This trial has 1 study location across Ohio. Contact the study sites directly through ClinicalTrials.gov for enrollment availability.
Learn More About Clinical Trials
Similar trials for Osteoporosis
Matched on the same primary condition, ranked to surface studies in the same phase first, then by recruiting status, no relevance scoring or editorial curation.
Where NCT00000402's enrollment target sits among peer trials
354 24th of 84 higher than 60 of 84 other Osteoporosis trials
participants (enrollment target), bucketed by value
Each bar is a band; taller bars hold more other Osteoporosis trials. The dashed line + filled bar mark this entry. Hover or tap any bar for its full count and share, and where it sits relative to this entry.
Source ClinicalTrials.gov registry export · 2026-08-08
-
Effect of Acetylcholinesterase Inhibitors on Bone Metabolism
RECRUITING · Phase 2
-
Comparison Study of PTHrP and PTH to Treat Osteoporosis
COMPLETED · Phase 2
-
Hormone Replacement Therapy to Treat Turner Syndrome
COMPLETED · Phase 2
-
Prevention of Bone Loss After Acute SCI by Zoledronic Acid
COMPLETED · Phase 2
-
12 Month Extension Study of the Effect of Teriparatide on Bone in People With Chronic Spinal Cord Injury (SCI)
COMPLETED · Phase 2
-
Adding Phosphorus to Osteoporosis Drug Treatment
COMPLETED · Phase 2
Nationwide trials with similar profiles
Cross-condition peers matched on enrollment target and registry start date, not the same-condition list above.
Similar enrollment target
- NCT02579967 · 354 participants · Phase 2
Pilot Trial of Allogeneic Blood or Marrow Transplantation for Primary Immunodeficiencies
- NCT02610413 · 354 participants
Whole Exome Sequencing in Finding Causative Variants in Germline DNA Samples From Patients With Hypertension Receiving Bevacizumab for Breast Cancer
- NCT05729256 · 354 participants · NA
Alcohol and "Heat of the Moment" Sexual Decision Making
- NCT06507618 · 354 participants · Phase 3
Pre-Operative Window of ET to Inform RT Decisions (POWER II)
Similar registry start date
- NCT05988463 · started 2027-01-01 · Phase 1
Dose-Escalation Study of Artesunate Patients With IPF
- NCT07219706 · started 2026-12-10 · NA
Dietary Fiber and Time Restricted Eating
- NCT02831335 · started 2026-12-01
Technical Development of Multi-Parametric Renocerebral MRI
- NCT05962346 · started 2026-12 · NA
Fetal Endoscopic Tracheal Occlusion for Congenital Diaphragmatic Hernia